4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000035
Chief Medical Officer sold 7,000 shares at an average $66.12 ($462,830)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 36,877 | D |
| 2026-04-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 40,377 | D |
| 2026-04-15 | Sale : show line 3 in the form 10b5-1 | −4,227 | $65.73 | $277,837 | 36,150 | D |
| 2026-04-15 | Sale : show line 4 in the form 10b5-1 | −2,273 | $66.56 | $151,301 | 33,877 | D |
| 2026-04-15 | Sale : show line 5 in the form 10b5-1 | −500 | $67.38 | $33,692 | 33,377 | D |
| Open-market sales · 7,000 sh · avg $66.12 · $462,830 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-15 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 211,063 | D |
| 2026-04-15 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 182,492 | D |
Loading xslF345X06/form4.xml…